FIELD: medicine.
SUBTANCE: group of inventions relates to the field of medicine, namely, to a pharmaceutical composition for the treatment and prevention of cardiovascular diseases in the form of a gelatin capsule containing calcium atorvastatin and perindopril arginine, each of which is in the form of minigranules, in combination with one or more pharmacologically acceptable auxiliary substances, and also relates to the use of a pharmaceutical composition in the treatment and prevention of cardiovascular diseases.
EFFECT: group of inventions provides the effectiveness, tolerance, and stability of the composition.
7 cl, 1 dwg, 8 tbl, 7 ex
Authors
Dates
2021-07-06—Published
2016-08-26—Filed